Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience

People living with HIV (PLWH) are at high risk of herpes zoster (HZ). The recombinant anti-HZ vaccine (RZV), approved by European Medicines Agency (EMA) in 2018, has been shown to be effective and safe in PLWH. This study aims to describe the implementation of RZV in our center. Prospective cohort s...

Descripción completa

Detalles Bibliográficos

Autores principales:	Benedetta Trentacapilli, Angelo Roberto Raccagni, Sara Diotallevi, Silvia Nozza, Riccardo Lolatto, Anna Carole D’Amelio, Gaia Catalano, Giacomo Ponta, Vincenzo Spagnuolo, Massimo Cernuschi, Nicola Gianotti, Antonella Castagna, Diana Canetti
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-02-01
Colección:	Frontiers in Virology
Materias:	herpes zoster proactive vaccination HIV implementation prioritization
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fviro.2025.1537821/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!